These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32314601)

  • 1. Discovery of necrosis avidity of rhein and its applications in necrosis imaging.
    Zhang D; Jin Q; Ni Y; Zhang J
    J Drug Target; 2020 Nov; 28(9):904-912. PubMed ID: 32314601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium.
    Wang Q; Yang S; Jiang C; Li J; Wang C; Chen L; Jin Q; Song S; Feng Y; Ni Y; Zhang J; Yin Z
    Sci Rep; 2016 Feb; 6():21341. PubMed ID: 26878909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium.
    Luo Q; Jin Q; Su C; Zhang D; Jiang C; Fish AF; Feng Y; Ni Y; Zhang J; Yin Z
    Anal Chem; 2017 Jan; 89(2):1260-1266. PubMed ID: 27981843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis.
    Zhang A; Wu T; Bian L; Li P; Liu Q; Zhang D; Jin Q; Zhang J; Huang G; Song S
    Mol Imaging Biol; 2020 Jun; 22(3):515-525. PubMed ID: 31250330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhein-based necrosis-avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy.
    Wu T; Zhang J; Jin Q; Gao M; Zhang D; Zhang L; Feng Y; Ni Y; Yin Z
    Magn Reson Med; 2019 Dec; 82(6):2212-2224. PubMed ID: 31418484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Evaluation of Rhein-Based MRI Contrast Agents for Visualization of Tumor Necrosis Induced by Combretastatin A-4 Disodium Phosphate.
    Zhang L; Zhang D; Gao M; Jin Q; Jiang C; Wu T; Feng Y; Ni Y; Yin Z; Zhang J
    Mol Imaging Biol; 2021 Apr; 23(2):220-229. PubMed ID: 33048270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPECT Imaging of Treatment-Related Tumor Necrosis Using Technetium-99m-Labeled Rhein.
    Liang J; Luo Q; Zhang D; Jin Q; Liu L; Liu W; Gao M; Zhang J; Yin Z
    Mol Imaging Biol; 2019 Aug; 21(4):660-668. PubMed ID: 30338432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis.
    Bian L; Gao M; Zhang D; Ji A; Su C; Duan X; Luo Q; Huang D; Feng Y; Ni Y; Yin Z; Jin Q; Zhang J
    Anal Chem; 2018 Nov; 90(22):13249-13256. PubMed ID: 30379067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging.
    Jiang B; Wang J; Ni Y; Chen F
    Theranostics; 2013; 3(9):667-76. PubMed ID: 24052807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of myocardial necrosis: an updated mini-review.
    Zhang D; Jiang C; Feng Y; Ni Y; Zhang J
    J Drug Target; 2020 Jul; 28(6):565-573. PubMed ID: 32037899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Evaluation of Radioiodinated Flavonoids as Necrosis-Avid Agents and Application in Early Assessment of Tumor Necrosis.
    Liang J; Sun Z; Zhang D; Jin Q; Cai L; Ma L; Liu W; Ni Y; Zhang J; Yin Z
    Mol Pharm; 2018 Jan; 15(1):207-215. PubMed ID: 29226682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target identification and occupancy measurement of necrosis avid agent rhein using bioorthogonal chemistry-enabling probes.
    Jiang C; Zhang J; Hu S; Gao M; Zhang D; Yao N; Jin Q
    RSC Adv; 2022 Jun; 12(26):16491-16495. PubMed ID: 35754899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-fibrotic and anti-tumorigenic effects of rhein, a natural anthraquinone derivative, in mammalian stellate and carcinoma cells.
    Tsang SW; Bian ZX
    Phytother Res; 2015 Mar; 29(3):407-14. PubMed ID: 25510440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Metabolism and Pharmacokinetics of Rhein and Aurantio-Obtusin.
    Xiao SL; Guan LJ; Jiang RF; Wang XG; Li X; Cai W
    Curr Drug Metab; 2020; 21(12):960-968. PubMed ID: 32682364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
    Cho JH; Chae JI; Shim JH
    Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhein Derivatives, A Promising Pivot?
    Pei R; Jiang Y; Lei G; Chen J; Liu M; Liu S
    Mini Rev Med Chem; 2021; 21(5):554-575. PubMed ID: 33167832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic analysis of rhein in Rheum undulatum L.
    Lee JH; Kim JM; Kim C
    J Ethnopharmacol; 2003 Jan; 84(1):5-9. PubMed ID: 12499069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental evaluation of radioiodinated sennoside B as a necrosis-avid tracer agent.
    Zhang D; Huang D; Ji Y; Jiang C; Li Y; Gao M; Yao N; Liu X; Shao H; Jing S; Ni Y; Yin Z; Zhang J
    J Drug Target; 2015 Feb; 23(2):180-90. PubMed ID: 25330022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
    Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
    Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination.
    Wang L; Pan X; Sweet DH
    Biochem Pharmacol; 2013 Oct; 86(7):991-6. PubMed ID: 23973525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.